467 related articles for article (PubMed ID: 17316406)
1. Refractory epilepsy: clinical overview.
French JA
Epilepsia; 2007; 48 Suppl 1():3-7. PubMed ID: 17316406
[TBL] [Abstract][Full Text] [Related]
2. The potential of pharmacogenetics in the treatment of epilepsy.
Depondt C
Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
[TBL] [Abstract][Full Text] [Related]
3. Quantifying the response to antiepileptic drugs: effect of past treatment history.
Schiller Y; Najjar Y
Neurology; 2008 Jan; 70(1):54-65. PubMed ID: 18166707
[TBL] [Abstract][Full Text] [Related]
4. Plasticity of antiepileptic drug targets.
Beck H
Epilepsia; 2007; 48 Suppl 1():14-8. PubMed ID: 17316408
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.
Schmidt D; Löscher W
Epilepsia; 2005 Jun; 46(6):858-77. PubMed ID: 15946327
[TBL] [Abstract][Full Text] [Related]
6. Refractory epilepsy: a clinically oriented review.
Beleza P
Eur Neurol; 2009; 62(2):65-71. PubMed ID: 19521080
[TBL] [Abstract][Full Text] [Related]
7. The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview.
Ferraro TN; Buono RJ
Epilepsy Behav; 2005 Aug; 7(1):18-36. PubMed ID: 15979945
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs.
Anderson GD
Ther Drug Monit; 2008 Apr; 30(2):173-80. PubMed ID: 18367977
[TBL] [Abstract][Full Text] [Related]
9. Likelihood of seizure remission in an adult population with refractory epilepsy.
Callaghan BC; Anand K; Hesdorffer D; Hauser WA; French JA
Ann Neurol; 2007 Oct; 62(4):382-9. PubMed ID: 17880009
[TBL] [Abstract][Full Text] [Related]
10. Response to antiepileptic drug therapy: winners and losers.
Brodie MJ
Epilepsia; 2005; 46 Suppl 10():31-2. PubMed ID: 16359468
[TBL] [Abstract][Full Text] [Related]
11. Can drug resistance in epilepsy be minimized? Challenging commonly held beliefs.
Perucca E
Epileptic Disord; 2005 Sep; 7 Suppl 1():S14-21. PubMed ID: 16120489
[TBL] [Abstract][Full Text] [Related]
12. Considerations in the choice of an antiepileptic drug in the treatment of epilepsy.
Azar NJ; Abou-Khalil BW
Semin Neurol; 2008 Jul; 28(3):305-16. PubMed ID: 18777477
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic strategies in the choice of antiepileptic drugs.
de Borchgrave V; Delvaux V; de Tourchaninoff M; Dubru JM; Ghariani S; Grisar T; Legros B; Ossemann M; Sadzot B; Tugendhaft P; Van Bogaert P; van Rijckevorsel K;
Acta Neurol Belg; 2002 Mar; 102(1):6-10. PubMed ID: 12094563
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in elderly patients with newly diagnosed and treated epilepsy.
Brodie MJ; Stephen LJ
Int Rev Neurobiol; 2007; 81():253-63. PubMed ID: 17433929
[TBL] [Abstract][Full Text] [Related]
15. [Drug-resistant epilepsy].
Nakken KO; Taubøll E
Tidsskr Nor Laegeforen; 2009 Oct; 129(19):1986-9. PubMed ID: 19823202
[TBL] [Abstract][Full Text] [Related]
16. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy.
Luciano AL; Shorvon SD
Ann Neurol; 2007 Oct; 62(4):375-81. PubMed ID: 17253624
[TBL] [Abstract][Full Text] [Related]
17. Drug treatment of epilepsy: options and limitations.
Schmidt D
Epilepsy Behav; 2009 May; 15(1):56-65. PubMed ID: 19236951
[TBL] [Abstract][Full Text] [Related]
18. [Genetic aspects of epilepsy].
Gandelman-Marton R; Neufeld MY
Harefuah; 2008 Feb; 147(2):139-44, 182. PubMed ID: 18357672
[TBL] [Abstract][Full Text] [Related]
19. Epilepsy in the elderly.
Leppik IE
Epilepsia; 2006; 47 Suppl 1():65-70. PubMed ID: 17044830
[TBL] [Abstract][Full Text] [Related]
20. Monitoring gene changes during antiepileptic drug therapy to widen the safety window and reduce pharmacoresistance.
Glauser TA
Epilepsia; 2007; 48 Suppl 1():19-25. PubMed ID: 17316409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
